GOSSAMER BIO INC (GOSS) Forecast, Price Target & Analyst Ratings

NASDAQ:GOSS • US38341P1021

Current stock price

0.3285 USD
+0.01 (+2.66%)
At close:
0.3222 USD
-0.01 (-1.92%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GOSSAMER BIO INC (GOSS).

Forecast Snapshot

Consensus Price Target

Price Target
$4.44
+ 1,250.68% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.18
Revenue Estimate
4.804M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
74.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.44
Upside
+ 1,250.68%
From current price of $0.33 to mean target of $4.44, Based on 15 analyst forecasts
Low
$0.30
Median
$2.04
High
$15.75

Price Target Revisions

1 Month
-53.15%
3 Months
-53.86%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for GOSS. The average price target is 4.44 USD. This implies a price increase of 1250.68% is expected in the next year compared to the current price of 0.3285.
The average price target has been revised downward by 53.86% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

GOSS Current Analyst RatingGOSS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

GOSS Historical Analyst RatingsGOSS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
74.67%
GOSS was analyzed by 15 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about GOSS.
In the last month the buy percentage fell by 9 points. So the trust of analysts is decreasing.
GOSS was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-23Cantor FitzgeraldDowngrade Overweight -> Neutral
2026-03-06HC Wainwright & Co.Maintains Buy -> Buy
2026-03-05OppenheimerMaintains Outperform -> Outperform
2026-02-24Leerink PartnersDowngrade Outperform -> Market Perform
2026-02-24BarclaysDowngrade Overweight -> Underweight
2026-02-24WedbushDowngrade Outperform -> Neutral
2026-01-28BarclaysInitiate Overweight
2026-01-22HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-11Cantor FitzgeraldReiterate Overweight -> Overweight
2025-09-10UBSUpgrade Neutral -> Buy
2025-08-06WedbushMaintains Outperform -> Outperform
2025-07-14ScotiaBankInitiate Sector Outperform
2025-05-16WedbushReiterate Outperform -> Outperform
2025-05-16Goldman SachsMaintains Buy -> Buy
2025-04-17Goldman SachsMaintains Buy -> Buy
2025-03-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-14WedbushReiterate Outperform -> Outperform
2025-01-30HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-17HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-30HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-13WedbushReiterate Outperform -> Outperform
2024-06-25OppenheimerInitiate Outperform
2024-06-17Goldman SachsMaintains Buy -> Buy
2024-05-20HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.18
Revenue Estimate
4.804M
Revenue Q2Q
-51.42%
EPS Q2Q
-9.49%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
-18.42%
Revenue (3 Months)
-18.42%
EPS (1 Month)
8.24%
EPS (3 Months)
9.61%

Next Earnings Summary

GOSS is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.18 USD and the consensus revenue estimate is 4.80M USD.
The next earnings revenue estimate has been revised downward by 18.42% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
GOSS revenue by date.GOSS revenue by date.
114.701M48.471M
-57.74%		32.159M
-33.65%		79.698M
147.82%		164.87M
106.87%		366.57M
122.34%		712.14M
94.27%		579.87M
-18.57%		717.86M
23.80%		864.27M
20.40%
EBITDA
YoY % growth
GOSS ebitda by date.GOSS ebitda by date.
-172.152M
20.55%		-59.086M
65.68%		-163.229M
-176.26%		-115.987M
28.94%		-63.181M
45.53%		19.38M
130.67%		106.9M
451.60%		240.82M
125.28%		N/AN/AN/A
EBIT
YoY % growth
GOSS ebit by date.GOSS ebit by date.
-173.759M
20.48%		-59.919M
65.52%		-163.253M
-172.46%		-138.547M
15.13%		-73.081M
47.25%		487.856K
100.67%		130.57M
26,664.06%		456.4M
249.54%		249.64M
-45.30%		367.69M
47.29%		506.37M
37.72%
Operating Margin
GOSS operating margin by date.GOSS operating margin by date.
N/A-52.24%-336.81%-430.82%-91.70%0.30%35.62%64.09%43.05%51.22%58.59%
EPS
YoY % growth
GOSS eps by date.GOSS eps by date.
-1.39
49.27%		-0.26
81.29%		-0.75
-188.46%		-0.54
27.45%		-0.15
72.50%		0.32
311.36%		0.24
-24.74%		0.27
14.32%		0.48
76.23%		0.71
47.51%		0.96
36.06%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.18
-9.49%		-0.13
24.02%		-0.12
45.24%		-0.09
56.83%		-0.10
44.69%		-0.07
44.72%		-0.02
86.70%		0.04
145.00%
Revenue
Q2Q % growth		4.804M
-51.42%		3.937M
-65.73%		2.947M
-77.83%		5.35M
-61.23%		2.142M
-55.41%		8.721M
121.51%		25.934M
780.01%		47.323M
784.54%
EBITDA
Q2Q % growth		-19.815M
46.16%		-17.088M
55.91%		-20.657M
50.37%		-17.48M
62.01%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-38.211M
-3.80%		-32.114M
17.16%		-31.05M
25.43%		-28.557M
37.97%		-32.876M
13.96%		-17.368M
45.92%		1.719M
105.54%		29.447M
203.11%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GOSS Yearly Revenue VS EstimatesGOSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
GOSS Yearly EPS VS EstimatesGOSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
34.29%
EPS Next 5 Year
18.76%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
55.41%
Revenue Next 5 Year
74.57%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
28.30%
EBIT Next 5 Year
27.65%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

GOSSAMER BIO INC / GOSS Forecast FAQ

Can you provide the average price target for GOSSAMER BIO INC stock?

15 analysts have analysed GOSS and the average price target is 4.44 USD. This implies a price increase of 1250.68% is expected in the next year compared to the current price of 0.3285.

When does GOSSAMER BIO INC (GOSS) report earnings?

GOSSAMER BIO INC (GOSS) will report earnings on 2026-05-13, after the market close.

What are the consensus estimates for GOSS stock next earnings?

The consensus EPS estimate for the next earnings of GOSSAMER BIO INC (GOSS) is -0.18 USD and the consensus revenue estimate is 4.80M USD.

What is the expected long term growth rate for GOSSAMER BIO INC (GOSS)?

The expected long term growth rate for GOSSAMER BIO INC (GOSS) is 55.41%.